Axsm stock zacks

Jan 28, 2020 · The Zacks Consensus EPS estimate has moved 2.33% higher within the past month. AXSM currently has a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 78, which puts it in the top 31% of all 250+ industries. Axsome Therapeutics (NASDAQ:AXSM) Stock Rating Lowered by ... Zacks Investment Research downgraded shares of Axsome Therapeutics (NASDAQ:AXSM) from a hold rating to a sell rating in a research note released on Friday, Zacks.com reports. According to Zacks, “Axsome Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing novel therapies for the management of pain and other central nervous system disorders. […]

AXSM: Axsome Therapeutics, Inc. - Zacks Investment Research AXSM: Axsome Therapeutics, Inc. - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Axsome Therapeutics, Inc. from Zacks Investment Research Brokerage Recommendations - Zacks Investment Research AXSM: Axsome Therapeutics, Inc. broker recommendations. Get the latest broker recommendations from Zacks Investment Research. Axsome Therapeutics (AXSM) Gains But Lags Market: What You ... AXSM currently has a Zacks Rank of #3 (Hold). Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus

AXSM Stock | AXSOME THERAPEUTICS Stock Price Today ...

Axsome Therapeutics (NASDAQ:AXSM) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Axsome Therapeutics, Inc. is a biopharmaceutical company. The company is focused on AXSM - Axsome Thera News - Barchart.com Axsome (AXSM) Completes Patient Randomization in TRD Study Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 8:34AM CST Zacks Equity Research - ZACKS - Thu Jan 23, 8:34AM CST Axsome (AXSM) closes patient randomization in the late-stage study of AXS-05 for addressing patients with treatment resistant depression. Axsome (AXSM) Completes Patient Randomization in TRD Study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Axsome Therapeutics, Inc. (AXSM): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research

Dec 03, 2019 · Investors in Axsome Therapeutics, Inc. AXSM need to pay close attention to the stock based on moves in the options market lately. That is because … Zacks Investment Research Downgrades Axsome Therapeutics ...

23 Mar 2018 Detailed price information for Axsome Thera (AXSM-Q) from The Globe Corporate earnings are provided from Zacks Investment Research, Download a comprehensive report detailing quantitative analytics of this equity.

Implied Volatility Surging for Axsome (AXSM) Stock Options. 07-12 zacks.com - 1 Investors in Axsome Therapeutics, Inc. (AXSM - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 16, 2019 $22.50 Put had some of the highest implied volatility of all equity options today. AXSM

Jan 23, 2020 · Axsome Therapeutics, Inc. AXSM announced that it has completed patient randomization in the phase III STRIDE-1 (Symptom Treatment in Resistant …

Axsome Therapeutics (NASDAQ:AXSM) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Friday, Zacks.com reports. According to Zacks, “Axsome Therapeutics, Inc. is a biopharmaceutical company. The company is focused on AXSM - Axsome Thera News - Barchart.com Axsome (AXSM) Completes Patient Randomization in TRD Study Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 8:34AM CST Zacks Equity Research - ZACKS - Thu Jan 23, 8:34AM CST Axsome (AXSM) closes patient randomization in the late-stage study of AXS-05 for addressing patients with treatment resistant depression.

17 hours ago · Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any …